XML 46 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation, Activity
The following table summarizes the Company’s restricted stock unit activity for 2016:
 
Shares
(in thousands)
 
 
Weighted Average Fair Value per Share at Grant Date
Nonvested at December 31, 2015

 
 
$

Granted
112

 
 
10.31

Vested

 
 

Canceled
(9
)
 
 
10.35

Nonvested at December 31, 2016
103

 
 
10.31

:
 
Shares
(in thousands)
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Term (years)
 
Aggregate
Intrinsic
Value
(in thousands)
Outstanding at December 31, 2015
2,714

 
$
17.18

 
 
 
 
Granted
902

 
$
10.02

 
 
 
 
Exercised
(6
)
 
$
7.27

 
 
 
 
Canceled
(325
)
 
$
19.88

 
 
 
 
Outstanding at December 31, 2016
3,285

 
$
15.46

 
7.5
 
$
2,458

Exercisable at December 31, 2016
1,887

 
$
17.76

 
6.5
 
$
651

Vested and expected to vest at December 31, 2016
3,196

 
$
15.56

 
7.5
 
$
2,340

Assumptions used in the Black-Scholes Option-Pricing Model
The assumptions used in the Black-Scholes option-pricing model are as follows:
 
Year Ended December 31,
 
2016
 
2015
 
2014
Stock Options
 
 
 
 
 
Risk free interest rate
1.1% to 2.1%
 
1.5% to 1.9%
 
1.6% to 2.0%
Expected term
5.1 to 6.1 years
 
5.1 to 6.1 years
 
5.1 to 6.1 years
Expected volatility
76.5 to 78.1%
 
76.7 to 79.2%
 
79.7 to 84.9%
Expected dividend yield
—%
 
—%
 
—%
Weighted-average fair value of option on grant date
$6.69
 
$8.37
 
$18.58
 
 
 
 
 
 
Employee Stock Purchase Plan
 
 
 
 
 
Risk free interest rate
0.5% to 0.8%
 
0.1% to 0.5%
 
0.1%
Expected term
0.5 to 1.0 years
 
0.5 to 1.0 years
 
0.5 to 1.0 years
Expected volatility
59.5% to 71.3%
 
67.4% to 77.8%
 
65.0% to 83.2%
Expected dividend yield
—%
 
—%
 
—%
Stock-Based Compensation Expense
The Company recognized stock-based compensation expense in continuing operations as follows (in thousands):
 
Year Ended December 31,
 
2016
 
2015
 
2014
Cost of revenue
$
386

 
$
390

 
$
467

Research and development
1,924

 
1,266

 
1,236

Selling, general and administrative
5,043

 
5,285

 
5,833

Total
$
7,353

 
$
6,941

 
$
7,536